Viatris Inc (VTRS) — Technical state
As of 2026-11-05 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Signal: Uptrend stack intact — Trades +7.5% vs the 50-day and +18.9% vs the 200-day average, 5% below the 52-week high and +96.5% off the 52-week low. Computed from daily closes. (as of 2026-11-05)
- Trend: Viatris Inc trades 7.5% above its 50-day and 18.9% above its 200-day moving average. (as of 2026-11-05)
Viatris is a healthcare company that sells prescription brand drugs, generics, complex generics and biosimilars across four regional units covering North America, Europe, Greater China and emerging markets. It supplies treatments spanning cardiovascular, diabetes, oncology, respiratory and other therapeutic areas, and distributes through wholesalers, pharmacies and specialty channels.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the VTRS overview. Research diary readings, not advice.
Trades +7.5% vs the 50-day and +18.9% vs the 200-day average, 5% below the 52-week high and +96.5% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day+3%
- vs 50-day+7.5%
- vs 200-day+18.9%
- 52-week band5% off the high · +96.5% off the low
- Streak1 consecutive down session
- 50-day crossprice crossed up through the 50-day 36 sessions ago
- Stochastic%K 52.9 · %D 70.9 · bear cross
Continue: the VTRS chart & overview · the signal board
FAQ · from the current data · as of 2026-11-05
Quick answers
What is the current Closelooknet signal on VTRS?
Uptrend stack intact — Trades +7.5% vs the 50-day and +18.9% vs the 200-day average, 5% below the 52-week high and +96.5% off the 52-week low. Computed from daily closes. As of 2026-11-05; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is VTRS above its 50-day and 200-day moving averages?
As of 2026-11-05, Viatris Inc trades +7.5% above its 50-day and +18.9% above its 200-day average, with the 20-day +3% away.
How far is VTRS from its 52-week high?
5% below the 52-week high and 96.5% above the 52-week low, as of 2026-11-05.
Related in the Closelooknet universe
then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- GALDY GALDERMA GROUP AGindustry
- IRWD Ironwood Pharmaceuticals Incindustry
- ALM.MC Almirall S.A.industry
- FAGR.BR Fagron NVindustry
- BHC.TO Bausch Health Companies Incindustry
- XERS Xeris Pharmaceuticals Incindustry
- PCRX Pacira BioSciences, Inc.industry
- HLUN-B.CO H Lundbeck A/Sindustry
- VETO.PA Vetoquinolindustry
- CRON Cronos Group Incindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- AMPH Amphastar Pindustry
- GUD.TO Knight Therapeutics Inc.industry
- NBIX Neurocrine Biosciences Incindustry
- 000538.SHE Yunnan Baiyao Group Co Ltdindustry
- UTHR United Therapeutics Corporationindustry
- PRGO Perrigo Company PLCindustry
- FAE.MC Faes Farma SAindustry
- DHT-UN.TO DRI Healthcare Trustindustry